GlassScriptPhysician profile
Gilbert C Foster
NPI 1649262726
$9,886.31
in general payments reported to CMS, 2019-2025
51 companies · $1,586 in 2025
The $1,586 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,651 · 2020: $943 · 2021: $919 · 2022: $1,357 · 2023: $1,702 · 2024: $1,728 · 2025: $1,586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,016.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,337.06 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,156.91 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $927.81 | 2019-2025 | |
| Lilly USA, LLC | $850.34 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $479.19 | 2019-2025 | Repatha, Otezla, Otezla |
| Supernus Pharmaceuticals, INC. | $465.91 | 2019-2025 | Qelbree, Qelbree |
| Merck Sharp & Dohme LLC | $435.60 | 2019-2024 | Gardasil 9, Vaxelis, Gardasil |
| Abbott Laboratories | $386.27 | 2021-2025 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $385.20 | 2019-2025 | Xifaxan, Trulance |
| Glaxosmithkline, LLC. | $301.58 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Allergan, INC. | $241.47 | 2019-2020 | |
| Astellas Pharma US INC | $203.16 | 2019-2024 | Veozah |
| Janssen Pharmaceuticals, INC | $188.25 | 2022-2025 | Spravato |
| Eisai INC. | $187.99 | 2024-2025 | |
| Corium, LLC | $184.10 | 2023-2024 | Azstarys |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gilbert Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.